315 related articles for article (PubMed ID: 17689623)
1. Transdermal hormonal contraception: benefits and risks.
Burkman RT
Am J Obstet Gynecol; 2007 Aug; 197(2):134.e1-6. PubMed ID: 17689623
[TBL] [Abstract][Full Text] [Related]
2. Transdermal delivery of sex steroids for hormone replacement therapy and contraception. A review of principles and practice.
Henzl MR; Loomba PK
J Reprod Med; 2003 Jul; 48(7):525-40. PubMed ID: 12953327
[TBL] [Abstract][Full Text] [Related]
3. Evra contraceptive patch: risks of thromboembolism.
Prescrire Int; 2007 Jun; 16(89):113-4. PubMed ID: 17590909
[No Abstract] [Full Text] [Related]
4. Further results on the risk of nonfatal venous thromboembolism in users of the contraceptive transdermal patch compared to users of oral contraceptives containing norgestimate and 35 microg of ethinyl estradiol.
Jick S; Kaye JA; Li L; Jick H
Contraception; 2007 Jul; 76(1):4-7. PubMed ID: 17586129
[TBL] [Abstract][Full Text] [Related]
5. The transdermal contraceptive patch: a new approach to hormonal contraception.
Burkman RT
Int J Fertil Womens Med; 2002; 47(2):69-76. PubMed ID: 11991433
[TBL] [Abstract][Full Text] [Related]
6. A clinical study of transdermal contraceptive patch in Thai adolescence women.
Piyasirisilp R; Taneepanichskul S
J Med Assoc Thai; 2008 Feb; 91(2):137-41. PubMed ID: 18389975
[TBL] [Abstract][Full Text] [Related]
7. Allergic contact dermatitis due to transdermal contraception patch.
Stricker T; Sennhauser FH
J Pediatr; 2006 Jun; 148(6):845. PubMed ID: 16769403
[No Abstract] [Full Text] [Related]
8. Comparing patient telephone callback rates for different hormonal birth control delivery systems.
Victor I; Fink RA
Am J Ther; 2006; 13(6):507-12. PubMed ID: 17122531
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics and pharmacodynamics of a transdermal contraceptive patch and an oral contraceptive.
Devineni D; Skee D; Vaccaro N; Massarella J; Janssens L; LaGuardia KD; Leung AT
J Clin Pharmacol; 2007 Apr; 47(4):497-509. PubMed ID: 17389559
[TBL] [Abstract][Full Text] [Related]
10. Venous thromboembolism, myocardial infarction, and stroke among transdermal contraceptive system users.
Cole JA; Norman H; Doherty M; Walker AM
Obstet Gynecol; 2007 Feb; 109(2 Pt 1):339-46. PubMed ID: 17267834
[TBL] [Abstract][Full Text] [Related]
11. Ethinylestradiol + norelgestromin: new preparation. Transdermal contraception: no tangible progress.
Prescrire Int; 2004 Aug; 13(72):123-6. PubMed ID: 15532134
[TBL] [Abstract][Full Text] [Related]
12. Oral and transdermal hormonal contraception in women after kidney transplantation.
Pietrzak B; Bobrowska K; Jabiry-Zieniewicz Z; Kaminski P; Wielgos M; Pazik J; Durlik M
Transplant Proc; 2007 Nov; 39(9):2759-62. PubMed ID: 18021980
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the contraceptive efficacy, compliance, and satisfaction with the transdermal contraceptive patch system Evra: a comparison between adolescent and adult users.
Bodner K; Bodner-Adler B; Grünberger W
Arch Gynecol Obstet; 2011 Mar; 283(3):525-30. PubMed ID: 20111970
[TBL] [Abstract][Full Text] [Related]
14. A clinical study of transdermal contraceptive patch in Thai women.
Suwanmalee O; Taneepanichskul S
J Med Assoc Thai; 2006 Oct; 89 Suppl 4():S1-4. PubMed ID: 17726805
[TBL] [Abstract][Full Text] [Related]
15. Newer non-oral hormonal contraception.
Bateson D; McNamee K; Briggs P
BMJ; 2013 Feb; 346():f341. PubMed ID: 23412438
[No Abstract] [Full Text] [Related]
16. Effects of oral and transdermal hormonal contraception on vascular risk markers: a randomized controlled trial.
Johnson JV; Lowell J; Badger GJ; Rosing J; Tchaikovski S; Cushman M
Obstet Gynecol; 2008 Feb; 111(2 Pt 1):278-84. PubMed ID: 18238963
[TBL] [Abstract][Full Text] [Related]
17. Adolescents' experiences using the contraceptive patch versus pills.
Sucato GS; Land SR; Murray PJ; Cecchini R; Gold MA
J Pediatr Adolesc Gynecol; 2011 Aug; 24(4):197-203. PubMed ID: 21454110
[TBL] [Abstract][Full Text] [Related]
18. Norelgestromin/ethinyl estradiol transdermal system.
Taneepanichskul S
J Med Assoc Thai; 2005 Oct; 88 Suppl 2():S82-4. PubMed ID: 17722322
[TBL] [Abstract][Full Text] [Related]
19. [Hormonal contraceptive patch].
Lidegaard O
Ugeskr Laeger; 2004 Oct; 166(41):3591. PubMed ID: 15515462
[No Abstract] [Full Text] [Related]
20. Risk of nonfatal venous thromboembolism in women using a contraceptive transdermal patch and oral contraceptives containing norgestimate and 35 microg of ethinyl estradiol.
Brenner P
Contraception; 2006 Oct; 74(4):354; author reply 354-5. PubMed ID: 16982246
[No Abstract] [Full Text] [Related]
[Next] [New Search]
